Below are the most recent publications written about "Neoplasm Grading" by people in Profiles.
-
Zhang S, Singh O, Dazelle K, Quezado M, Cimino PJ, Abdullaev Z, Wu J, Lucas CH, Schreck KC, Holdhoff M, Pytel P, Goodwill V, Macaulay R, McDonald W, Seidman R, Wood M, Bharani K, Neltner J, Richard H, Chang K, Szymanski L, Yip S, Mukherjee A, Lopes Abath Neto O, Sharma SJ, Green R, Brown D, Gubbiotti MA, Ballester LY, Eschbacher J, Smith-Cohn M, Gokden M, Vincentelli C, Yong W, Lee J, Mount C, Fulmer J, Sun M, Ligon K, Santi M, Pai EL, Yeaney G, Alexandrescu S, Raghavan R, Fernandes I, Reis GF, Mandel J, Caccamo D, Rao S, Butt OH, Dahiya S, Stone S, Conway K, Nasrallah MP, Fuller C, Toland A, Lukas RV, Cachia D, Uhlmann EJ, McCord M, Helgager J, Han K, Perry A, Perez S, Daoud E, BeDell D, Highfield H, Kobalka P, Nix JS, Nduom E, Neill S, Gilbert MR, Lakis N, Fonseca A, Shen C, Yoda R, Monterroza L, Cohen AL, Cathcart S, Al Amin M, Campian J, Aldape K. High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort. Neuro Oncol. 2026 Oct 01; 28(10):2435-2448.
-
Buller DM, Dubovic V, Martin WE, Rosenfeld B, Sherman A, Faust WC, Ginzburg S, Wagner JR, Correa AF, Pinto K, Albertsen PC, Kutikov A, Ristau BT. Multi-Institutional Assessment of Performance Metrics for MRI-Targeted Transperineal Prostate Biopsy. J Urol. 2026 Oct; 216(4):511-517.
-
Freitas AJA, Causin RL, Calfa S, Santana IVV, Balie M, Hirai W, Laus AC, Araujo HS, Hidalgo Filho CM, de Oliveira Bombarda F, da Silva VD, Evangelista AF, de Pádua Souza C, Reis RM, Marques MMC. Exploring the Nottingham classification: assessing gene expression profiles in breast cancer patients and their association with outcomes. Breast Cancer Res Treat. 2025 Jul; 212(2):237-250.
-
Bono BC, Grimi A, Di Toro AE, Ninatti G, Franzini A, Rossini Z, Tropeano MP, Navarria P, Bellu L, Simonelli M, Dipasquale A, Savini G, Levi R, Politi LS, Pessina F, Riva M. Preoperative Diffusion Tensor Imaging and Neurite Dispersion and Density Imaging in Isocitrate Dehydrogenase-Mutant Grade 2 and 3 Gliomas: Definition of Tumor-Related Epilepsy and Predictive Factors of Seizure Outcomes Based on a Single-Center Retrospective Case Series. Neurosurgery. 2025 Jan 29; 97(2):361-373.
-
Dahl DM, Rodgers JP, Shipley WU, Michaelson MD, Wu CL, Parker W, Jani AB, Cury FL, Hudes RS, Michalski JM, Hartford AC, Song D, Citrin DE, Karrison TG, Sandler HM, Feng FY, Efstathiou JA. Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926. J Clin Oncol. 2024 12; 42(34):4095-4102.
-
Nguyen PL, Huang HR, Spratt DE, Davicioni E, Sandler HM, Shipley WU, Efstathiou JA, Simko JP, Pollack A, Dicker AP, Roach M, Rosenthal SA, Zeitzer KL, Mendez LC, Hartford AC, Hall WA, Desai AB, Rabinovitch RA, Peters CA, Rodgers JP, Tran P, Feng FY. Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials. Int J Radiat Oncol Biol Phys. 2023 07 01; 116(3):521-529.
-
Clements MB, Vertosick EA, Guerrios-Rivera L, De Hoedt AM, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Haese A, Montorsi F, Boorjian SA, Poyet C, Ankerst DP, Vickers AJ. Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort. Eur Urol. 2022 08; 82(2):163-169.
-
Pockros B, Stensland KD, Parries M, Frankenberger E, Canes D, Moinzadeh A. Preoperative MRI PI-RADS scores are associated with prostate cancer upstaging on surgical pathology. Prostate. 2022 02; 82(3):352-358.
-
Bruand M, Barras D, Mina M, Ghisoni E, Morotti M, Lanitis E, Fahr N, Desbuisson M, Grimm A, Zhang H, Chong C, Dagher J, Chee S, Tsianou T, Dorier J, Stevenson BJ, Iseli C, Ronet C, Bobisse S, Genolet R, Walton J, Bassani-Sternberg M, Kandalaft LE, Ren B, McNeish I, Swisher E, Harari A, Delorenzi M, Ciriello G, Irving M, Rusakiewicz S, Foukas PG, Martinon F, Dangaj Laniti D, Coukos G. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Rep. 2021 07 20; 36(3):109412.
-
Marchocki Z, Cusimano MC, Clarfield L, Kim SR, Fazelzad R, Espin-Garcia O, Bouchard-Fortier G, Rossi EC, Stewart KI, Soliman PT, How JA, Gotlieb WH, Holloway RW, Ianieri MM, Cabrera S, Lim YK, Ferguson SE. Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics. Am J Obstet Gynecol. 2021 10; 225(4):367.e1-367.e39.